154 related articles for article (PubMed ID: 20596795)
1. Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients.
Brophy GM; Brackbill ML; Bidwell KL; Brophy DF
Neurocrit Care; 2010 Oct; 13(2):176-81. PubMed ID: 20596795
[TBL] [Abstract][Full Text] [Related]
2. Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers.
Nishino M; Sugimoto M; Kodaira C; Yamade M; Uotani T; Shirai N; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
J Clin Pharmacol; 2011 Jul; 51(7):1079-86. PubMed ID: 20663999
[TBL] [Abstract][Full Text] [Related]
3. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
[TBL] [Abstract][Full Text] [Related]
4. Early effects of intravenous administrations of lansoprazole and famotidine on intragastric pH.
Iida H; Inamori M; Akimoto K; Mawatari H; Endo H; Nozaki Y; Akiyama T; Ikeda T; Sakamoto Y; Fujita K; Yoneda K; Takahashi H; Yoneda M; Goto A; Abe Y; Kobayashi N; Kirikoshi H; Kubota K; Saito S; Nakajima A
Hepatogastroenterology; 2009; 56(90):551-4. PubMed ID: 19579641
[TBL] [Abstract][Full Text] [Related]
5. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
Hotz J; Kleinert R; Grymbowski T; Hennig U; Schwarz JA
Aliment Pharmacol Ther; 1992 Feb; 6(1):87-95. PubMed ID: 1543819
[TBL] [Abstract][Full Text] [Related]
6. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the enteral and intravenous lansoprazole pharmacodynamic responses in critically ill patients.
Olsen KM; Devlin JW
Aliment Pharmacol Ther; 2008 Aug; 28(3):326-33. PubMed ID: 19086331
[TBL] [Abstract][Full Text] [Related]
8. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Ogawa N
Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
[TBL] [Abstract][Full Text] [Related]
9. [Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion].
Inatomi N; Murakami I; Asano S; Inada I; Satoh H
Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):333-43. PubMed ID: 9017687
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: results of a prospective, randomized, crossover study.
Baghaie AA; Mojtahedzadeh M; Levine RL; Fromm RE; Guntupalli KK; Opekun AR
Crit Care Med; 1995 Apr; 23(4):687-91. PubMed ID: 7712759
[TBL] [Abstract][Full Text] [Related]
11. [Effects of lansoprazole on indomethacin-induced gastric bleeding and mucosal lesions in rats].
Murakami I; Asano S; Yukishige K; Nagaya H; Satoh H; Inatomi N
Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):323-32. PubMed ID: 9017686
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
Takeda H; Hokari K; Asaka M
J Clin Gastroenterol; 1995; 20 Suppl 1():S7-9. PubMed ID: 7673616
[TBL] [Abstract][Full Text] [Related]
13. Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial.
Okai T; Sawabu N; Songür Y; Motoo Y; Watanabe H
J Clin Gastroenterol; 1995; 20 Suppl 2():S32-5. PubMed ID: 7594335
[TBL] [Abstract][Full Text] [Related]
14. Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazole and famotidine.
Tsuji S; Kawano S; Higashi T; Mukuda T; Imaizumi T; Tatsumi T; Miura N; Miyajima K; Fukuda M; Noguchi M
J Clin Gastroenterol; 1995; 20 Suppl 2():S1-4. PubMed ID: 7594320
[TBL] [Abstract][Full Text] [Related]
15. Intravenous esomeprazole 40 mg vs. intravenous lansoprazole 30 mg for controlling intragastric acidity in healthy adults.
Pisegna JR; Sostek MB; Monyak JT; Miner PB
Aliment Pharmacol Ther; 2008 Mar; 27(6):483-90. PubMed ID: 18162083
[TBL] [Abstract][Full Text] [Related]
16. Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease.
Somberg L; Morris J; Fantus R; Graepel J; Field BG; Lynn R; Karlstadt R
J Trauma; 2008 May; 64(5):1202-10. PubMed ID: 18469642
[TBL] [Abstract][Full Text] [Related]
17. Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups.
Shirai N; Furuta T; Xiao F; Kajimura M; Hanai H; Ohashi K; Ishizaki T
Aliment Pharmacol Ther; 2002 Apr; 16(4):837-46. PubMed ID: 11929404
[TBL] [Abstract][Full Text] [Related]
18. Effect of acidified enteral feedings on gastric colonization in the critically ill patient.
Heyland D; Bradley C; Mandell LA
Crit Care Med; 1992 Oct; 20(10):1388-94. PubMed ID: 1395658
[TBL] [Abstract][Full Text] [Related]
19. Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status.
Furuta T; Shirai N; Sugimoto M; Nakamura A; Okudaira K; Kajimura M; Hishida A
Aliment Pharmacol Ther; 2005 Jul; 22(1):67-74. PubMed ID: 15963082
[TBL] [Abstract][Full Text] [Related]
20. Nasogastric lansoprazole is effective in suppressing gastric acid secretion in critically ill patients.
Tsai WL; Poon SK; Yu HK; Chang CS; Yeh HZ; Ko CW; Chen GH
Aliment Pharmacol Ther; 2000 Jan; 14(1):123-7. PubMed ID: 10632655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
